SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
23-May-24 10:00 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 21-May-24 | Grant | 4,410 | -- | -- | 12% 36.2K to 40.61K | |
18-Dec-23 7:34 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 14-Dec-23 | Option Exercise | 9,612 | -- | -- | 104% 9.24K to 18.86K | |
05-Dec-23 7:33 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 03-Dec-23 | Option Exercise | 1,537 | -- | -- | 20% 7.71K to 9.24K | |
24-May-23 4:33 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 23-May-23 | Grant | 6,865 | -- | -- | 23% 29.33K to 36.2K | |
16-Dec-22 8:02 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 14-Dec-22 | Option Exercise | 4,632 | -- | -- | 151% 3.07K to 7.71K | |
06-Dec-22 7:41 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 03-Dec-22 | Option Exercise | 1,537 | -- | -- | 100% 1.54K to 3.07K | |
29-Apr-22 6:26 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 27-Apr-22 | Grant | 10,049 | -- | -- | 52% 19.29K to 29.33K | |
22-Dec-21 8:06 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 20-Dec-21 | Market Purchase | 1,072 | $46.47 | $49,819.60 | 6% 16.71K to 17.79K | 3% |
07-Dec-21 7:13 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 03-Dec-21 | Option Exercise | 1,537 | -- | -- | 100% 0 to 1.54K | |
25-Mar-21 10:00 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 23-Mar-21 | Grant | 9,292 | -- | -- | 125% 7.42K to 16.71K | |
28-Jan-22 10:00 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 16-Mar-21 | Market Purchase | 1,500 | $33.22 | $49,830.00 | 8% 17.79K to 19.29K | 33% |
07-Aug-20 7:33 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 05-Aug-20 | Grant | 7,421 | -- | -- | 100% 0 to 7.42K |